LEJU yields 184.77% · JNJ yields 2.13%● Live data
📍 LEJU pulled ahead of the other in Year 1
Combined, LEJU + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LEJU + JNJ for your $10,000?
Leju Holdings Limited, through its subsidiaries, provides online to offline (O2O) real estate services in the People's Republic of China. It offers real estate e-commerce, online advertising, and online listing services through its online platform, which comprises websites covering 401 cities and various mobile applications. The company also operates various real estate and home furnishing Websites of SINA Corporation (SINA). Its O2O services for new residential properties include selling discount coupons; and facilitating online property viewing, physical property visits, marketing events, and pre-sale customer support, as well as home furnishing business transactions on its platform. In addition, the company sells advertising primarily on the SINA new residential properties and home furnishing websites; and acts as an advertising agent for the SINA home page and non-real estate Websites with respect to advertising sold to real estate developers and home furnishing suppliers. Further, it offers fee-based online property listing services to real estate agents; and services to individual property sellers. The company was incorporated in 2013 and is headquartered in Beijing, the People's Republic of China.
Full LEJU Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.